Has Şimşek, D. Et Al. 2021. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.. CLINICAL NUCLEAR MEDICINE , vol.7, no.46 , 579-581.

Has Şimşek, D., Civan, C., Erdem, S., & Şanlı, Y., (2021). Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.. CLINICAL NUCLEAR MEDICINE , vol.7, no.46, 579-581.

Has Şimşek, Duygu Et Al. "Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.," CLINICAL NUCLEAR MEDICINE , vol.7, no.46, 579-581, 2021

Has Şimşek, Duygu H. Et Al. "Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.." CLINICAL NUCLEAR MEDICINE , vol.7, no.46, pp.579-581, 2021

Has Şimşek, D. Et Al. (2021) . "Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.." CLINICAL NUCLEAR MEDICINE , vol.7, no.46, pp.579-581.

@article{article, author={Duygu HAS ŞİMŞEK Et Al. }, title={Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.}, journal={CLINICAL NUCLEAR MEDICINE}, year=2021, pages={579-581} }